Radiosensitization and DNA repair inhibition by pentoxifylline in NIH3T3 p53 transfectants

By Binder A.   Theron T.   Donninger H.   Parker M.   Bohm L.  

International Journal of Radiation Biology, Vol. 78, Iss. 11, 2002-11 ,pp. : 991-1000

Informa Healthcare

Access to resources Recommend Favorite

Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control

By Strunz A. M.   Peschke P.   Waldeck W.   Ehemann V.   Kissel M.   Debus J.  

International Journal of Radiation Biology, Vol. 78, Iss. 8, 2002-08 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

p53 status, cellular recovery and cell cycle arrest as prognosticators of in vitro radiosensitivity in human pancreatic adenocarcinoma cell lines

By Ng C. E.   Banerjee S. K.   Pavliv M.   Wang G.   Raaphorst G. P.   Aubin R. A.  

International Journal of Radiation Biology, Vol. 75, Iss. 11, 1999-11 ,pp. : 1365-1376

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status

By Minderman Hans   Zhou Yunfei   O’Loughlin Kieran   Baer Maria  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

The Status of p53 in the Metastatic Progression of Colorectal Cancer

By Heide I.   Thiede C.   Sonntag T.   de Kant E.   Neubauer A.   Jonas S.   Peter F.J.   Neuhaus P.   Herrmann R.   Huhn D.   Rochlitz C.F.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1314-1322

Elsevier

Access to resources Recommend Favorite